Lilly sues to stop generic Strattera
Indianapolis-based Eli Lilly and Co. is suing Sun Pharmaceutical Industries Ltd. of India to stop Sun from selling a generic version of its hyper-disorder drug Strattera. Lilly, which filed the suit in Detroit on Sept. 20, said it would be “irreparably harmed” if the generic wasn’t stopped, according to Bloomberg. Sun’s application to the U.S. […]